Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enteral naloxone for prevention of constipation in ventilated ICU patients
ACTRN12620000207910Phase 4Not yet recruiting
- Sponsor
- Dr Eamon Raith
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in constipation comparing Enteral naloxone with Enteral placebo (2 arms). Primary endpoint: Time to first bowel motion. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
naloxone
03
Conditions
constipation
Beyond the preview
Go deeper on ACTRN12620000207910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000207910.